Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.

Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses. Am J Geriatr Psychiatry. 2007 Nov; 15(11):918-31.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Alzheimer Disease
Antipsychotic Agents
Aripiprazole
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Female
Humans
Institutionalization
Male
Middle Aged
Piperazines
Placebos
Psychiatric Status Rating Scales
Psychomotor Agitation
Psychotic Disorders
Quinolones
Severity of Illness Index
Treatment Outcome

authors with profiles

Jacobo E Mintzer